New Standards Introduced for Liquid Biopsy Tests Monitoring Cancer Recurrence#USA#Chicago#Liquid_Biopsy#Cancer_Recurrence#BLOODPAC
New Standards Introduced for Liquid Biopsy Tests Monitoring Cancer Recurrence
The BLOODPAC Consortium has published a new document detailing standards for liquid biopsy tests in JCO Precision Oncology, aiming to enhance cancer care.
third-news.com
January 15, 2026 at 12:20 PM
New Standards Introduced for Liquid Biopsy Tests Monitoring Cancer Recurrence#USA#Chicago#Liquid_Biopsy#Cancer_Recurrence#BLOODPAC
BLOODPAC Sets New Standards for Liquid Biopsy Tests to Monitor Cancer Recurrence#USA#Chicago#Liquid_Biopsy#Cancer_Recurrence#BLOODPAC
BLOODPAC Sets New Standards for Liquid Biopsy Tests to Monitor Cancer Recurrence
BLOODPAC has published new standards for liquid biopsy tests aimed at monitoring cancer recurrence. This framework enhances test validation and patient care.
third-news.com
January 15, 2026 at 12:17 PM
BLOODPAC Sets New Standards for Liquid Biopsy Tests to Monitor Cancer Recurrence#USA#Chicago#Liquid_Biopsy#Cancer_Recurrence#BLOODPAC
Labcorp Expands MRD Testing to Enhance Detection of Cancer Recurrence for Breast, Lung, and Colon Cancers#United_States#Burlington#Labcorp#MRD_Testing#Cancer_Recurrence
Labcorp Expands MRD Testing to Enhance Detection of Cancer Recurrence for Breast, Lung, and Colon Cancers
Labcorp's recent expansion of molecular residual disease testing aims to provide early detection of cancer recurrence, improving patient care in breast, lung, and colon cancers.
third-news.com
January 13, 2026 at 12:25 PM
Labcorp Expands MRD Testing to Enhance Detection of Cancer Recurrence for Breast, Lung, and Colon Cancers#United_States#Burlington#Labcorp#MRD_Testing#Cancer_Recurrence